Your browser doesn't support javascript.
loading
Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2a study.
Yu, Hui Jing; Dickson, Samuel P; Wang, Pei-Ning; Chiu, Ming-Jang; Huang, Chin-Chang; Chang, Chiung-Chih; Liu, Hope; Hendrix, Suzanne B; Dodart, Jean-Cosme; Verma, Ajay; Wang, Chang Yi; Cummings, Jeffrey.
Afiliación
  • Yu HJ; Vaxxinity, Inc. (Formerly United Neuroscience Ltd.), Exploration Park, FL, USA. Electronic address: huijing@vaxxinity.com.
  • Dickson SP; Pentara, Millcreek, UT, USA.
  • Wang PN; Division of General Neurology, Department of Neurological Institute, Taipei Veterans General Hospital & Brain Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Chiu MJ; National Taiwan University Hospital, Taipei, Taiwan.
  • Huang CC; Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Chang CC; Department of Neurology, Cognition and Aging Center, Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
  • Liu H; United Biomedical, Inc. Asia, Zhubei City, Hsinchu, Taiwan.
  • Hendrix SB; Pentara, Millcreek, UT, USA.
  • Dodart JC; Vaxxinity, Inc. (Formerly United Neuroscience Ltd.), Exploration Park, FL, USA.
  • Verma A; Vaxxinity, Inc. (Formerly United Neuroscience Ltd.), Exploration Park, FL, USA.
  • Wang CY; United Biomedical, Inc. Asia, Zhubei City, Hsinchu, Taiwan; United Biomedical, Inc., Hauppauge, NY, USA.
  • Cummings J; Chambers-Grundy Center for Transformative Neuroscience, Pam Quirk Brain Health and Biomarker Laboratory, Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA.
EBioMedicine ; 94: 104665, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37392597
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas / Enfermedad de Alzheimer Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: EBioMedicine Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas / Enfermedad de Alzheimer Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: EBioMedicine Año: 2023 Tipo del documento: Article